Open AccessVernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation
Author(s) -
Denis Roy,
Craig M. Pratt,
Christian TorpPedersen,
D. George Wyse,
Egon Toft,
Steen JuulMöller,
Tonny Nielsen,
Scott Rasmussen,
Ian G. Stiell,
Benoit Coutu,
James E. Ip,
Edward L.C. Pritchett,
A. John Camm
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.723866
Subject(s) - medicine , atrial fibrillation , placebo , anesthesia , sinus rhythm , cardiology , alternative medicine , pathology
The present study assessed the efficacy and safety of vernakalant hydrochloride (RSD1235), a novel compound, for the conversion of atrial fibrillation (AF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom